论文部分内容阅读
CHARISMA(Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events)试验旨在比较阿司匹林单药治疗与阿司匹林和氯吡格雷联合治疗预防动脉粥样硬化事件的疗效。有26个国家参与了该项研究,
The CHARISMA (Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events) trial compared the efficacy of aspirin monotherapy with aspirin and clopidogrel in preventing atherosclerosis. Twenty-six countries participated in the study,